Disclosure Plus

COPUS KOREA Co., Ltd. "Files Lawsuit Seeking Declaration That New Share Issuance Is Invalid"

Shin Ha-yeon
2026-08-18 17:39:32
[E-Daily Reporter Shin Ha-yeon ] COPUS KOREA Co., Ltd.(322780)announced on the 18th that Mr. Shin Yi-cheol filed a lawsuit with the Seoul Western District Court seeking a declaration that the company’s issuance of new shares is invalid.

The plaintiff requested that the issuance of 5,716,461 new common shares—issued by COPUS KOREA Co., Ltd. pursuant to a board resolution on June 26—be declared invalid. The par value of the new shares is 500 won per share, and the issue price is 1,312 won per share, bringing the total issuance amount to approximately 7.5 billion won.

The company stated, “We plan to appoint legal counsel and respond in accordance with legal procedures to this lawsuit, which is based on claims that do not align with the facts.”

Economy

Corporation

IT·Science

Economy

Spreads Are Widening… Pension Funds Line Up with Large Sum of Money for Corporate Bonds

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-16 20:13:04

Corporation

Out of 253 Stocks, Only 21 Rose—Market in Shambles... DuChemBio Co, LTD, Yuhan, and Curiox Were the Exceptions [Bio Market Roundup]

On the 15th, the domestic pharmaceutical and biotech sector could not escape “Black Thursday.” Most stocks were unable to avoid declines. In the pharmaceutical sector, only 12 out of 161 stocks posted…
2026-10-17 07:21:02

IT·Science

Black Thursday: DuChemBio, Yuhan, and Curiox Emerge as Rare Bright Spots [K-BIO Pulse]

South Korea’s pharmaceutical and biotechnology sectors took a heavy hit on October 15, with the vast majority of stocks ending the session in negative territory. Of the 161 stocks in the pharmaceutica…
2026-10-17 07:21:03